Sektorale Bewertungen Laboratorios Farmaceuticos Rovi, S.A. Wiener Boerse
Aktien
ROVI
ES0157261019
ROVI
Pharmazeutika
|
Schlusskurs
Wiener Boerse
21.08.2026
|
% 5 Tage | Veränd. 1. Jan. | ||
| 59.60 EUR | -1.57% |
|
+3.47% | -5.85% |
| 23.07. | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 23.07. | Laboratorios Farmaceuticos Rovi, S.A. legt Ergebnisse für das Halbjahr bis zum 30. Juni 2026 vor | CI |
Hauptkonkurrenten
| KGV (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Dividendenrendite (Y) | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 35.74x | 22.68x | 0.67x | 12.95x | 26.26x | 27.83x | 0.55% | 1’119 Mrd. | ||
| 30.06x | - | -1.63x | - | - | - | 1.99% | 651 Mrd. | ||
| 33.82x | -371.14x | 0.15x | 7.82x | 16.26x | 16.9x | 2.59% | 468 Mrd. | ||
| 20.93x | 7.52x | 1.76x | 4.96x | 12.28x | 13.62x | 2.66% | 374 Mrd. | ||
| 22.59x | 6.36x | -9.48x | 5.81x | 14.4x | 15.36x | 2.75% | 302 Mrd. | ||
| 21.37x | 4.8x | 1.1x | 4.4x | 12.49x | 13.21x | 1.99% | 259 Mrd. | ||
| 27.79x | 20.99x | 2.5x | 7.17x | 12.73x | 16.45x | 2.3% | 238 Mrd. | ||
| 13.71x | 5.7x | -2.91x | 4.87x | 10.23x | 11.89x | 3.75% | 208 Mrd. | ||
| -44.65x | 9.95x | 0.3x | 6.45x | 25.18x | 61.67x | 2.26% | 181 Mrd. | ||
| 17.59x | 1.82x | 1.01x | 3.33x | 8.51x | 9.71x | 6.13% | 160 Mrd. | ||
| 32.32x | 6.18x | 3.02x | 9.34x | 21.11x | 22.02x | -.--% | 139 Mrd. | ||
| 11.94x | 5.63x | 0.19x | 3.32x | 8.62x | 9.35x | 3.77% | 137 Mrd. | ||
| 12.55x | 1.28x | -7.41x | 2.23x | 7.19x | 8x | 5.39% | 110 Mrd. | ||
| 14.5x | 4.67x | -2.32x | 2.83x | 8.38x | 9.32x | 3.63% | 105 Mrd. | ||
| 22.75x | 5.13x | 1.35x | 7.65x | 14.52x | 15.23x | 1.94% | 72.56 Mrd. | ||
| 46.91x | 1.23x | 64.6x | 2.8x | 9.87x | 29.51x | 3.54% | 57.89 Mrd. | ||
| 20.55x | 1.68x | -0.13x | 1.69x | 7.98x | 13.47x | 0.33% | 55.1 Mrd. | ||
| 34.82x | 4.63x | 2.15x | 8.05x | 27.37x | 28.3x | 0.54% | 46.76 Mrd. | ||
| 18.89x | 1.89x | 4.83x | 3.41x | 12.73x | 14.19x | 2.23% | 43.6 Mrd. | ||
| Durchschnitt | 20.74x | -14.39x | 3.15x | 5.50x | 14.23x | 18.67x | 2.54% | 248.78 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 24.70x | -32.16x | 0.33x | 7.59x | 17.16x | 20.37x | 2.15% |
- Börse
- Aktien
- A0M0GQ Aktie
- ROVI Aktie
- Sektor Laboratorios Farmaceuticos Rovi, S.A.
- Sektorale Bewertungen
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















